Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Website Tools
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Phase I Clinical Trial Units for Therapeutics

Prioritization and Approval Process

Concept proposals will be reviewed by the VTEU and Phase I clinical Trials Oversight Committee every 60 days according to the following criteria:

  • Public health significance
  • Appropiateness and feasibility of the study design
  • Available funding

Protocols for concepts approved by the Committee will be developed by the contractors in collaboration with the Division of Microbiology and Infectious Diseases.​

Last Updated November 13, 2012